Organ transplant milestone as Thermo Fisher launches robust diagnostic technologies

USA – Thermo Fisher Scientific has announced two new additions to its transplant diagnostics portfolio at the annual meeting for the American Society for Histocompatibility and Immunogenetics (ASHI). These new products will allow transplant laboratories to better characterize samples while also increasing speed and confidence. The transplant diagnostics market comprises of the sale of transplant diagnostics test products as well as related services. Transplant diagnostics are tests performed prior to the relocation or transplantation of a donor organ to a recipient patient. Human leukocyte antigen (HLA) diagnostic testing, PCR-based assay,…

Read More